7779 Stock | Chart | CYBERDYNE Inc Stock Price Today, Chart, performance

Short Term Long Term Short Term Comparison Long Term Comparison

7779
1d-1.01%
1w-1.01%
1m-4.37%
1y-31.36%
7779
1y-31.36%
5y-71.41%
10y-96.96%
20y0.00%

Bitcoin
-0.82%
-9.09%
-6.40%
106.24%
Bitcoin
106.24%
1,146.32%
11,770.30%
0.00%

Ethereum
-0.90%
-11.75%
-14.49%
45.57%
Ethereum
45.57%
1,828.08%
0.00%
0.00%

Gold
0.26%
2.56%
11.41%
20.52%
Gold
20.52%
88.92%
85.82%
499.35%

Silver
0.47%
4.25%
15.38%
14.30%
Silver
14.30%
94.94%
48.08%
306.93%

Apple
-2.19%
1.78%
0.04%
5.09%
Apple
5.09%
260.11%
-66.73%
39,041.00%

Amazon
-1.68%
-1.44%
4.92%
78.52%
Amazon
78.52%
96.45%
-43.46%
7,943.96%

Microsoft
-1.96%
-2.97%
-0.67%
45.75%
Microsoft
45.75%
259.81%
923.86%
2,532.12%

S&P 500
-1.20%
-2.84%
-1.08%
22.34%
S&P 500
22.34%
74.12%
171.80%
346.13%

Dow & Jones
-0.65%
-2.95%
-2.53%
11.36%
Dow & Jones
11.36%
42.65%
129.74%
261.03%

ATH

ATH Price$2,600.00
ATH Date2016-05-31
% since ATH-92.42%
% to ATH1,219.80%

ATL

ATL Price$199.00
ATL Date2024-04-03
% from ATL-1.00502513%
Last Low Price$199
Last Low Date2024-04-03
% From Last Low-1.00502513%

IPO

IPO Price$8,510.00
% Current ROI USD-97.69%
ATH Price$2,600.00
% ROI ATH 130,653.27%

[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="7779"]

Key Data [addtoany]

Current price	$197
Sector	Healthcare
Industry	Medical Devices
Today's High/Low	$198/$197
Volume	253,700.00
Previous Close	$199
52 Week High/Low	$357/$195
Market Cap	42,015,072,256.00
P/E Ratio	0
Forward P/E 1 Yr.	$0.00
Earnings Per Share(EPS)	$0.45
Annualized Dividend	$0

$197

[addtoany]

CYBERDYNE Inc. manufactures and sells medical devices in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use for people who have disorders in the lower limb and leg weaknesses, as well as non-medical HAL; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging.
It also provides HAL Therapy, a medical service to provide medical treatment for functional improvement of patients with cerebral, nervous, spinal cord injury, and cerebral embolism disorders; and non-medical services, such as HAL FIT and ROBO CARE training programs.
The company operates 16 Neuro HALFIT service centers. CYBERDYNE Inc. has a strategic partnership with CellSource Co., Ltd. to jointly discover new treatment methods for patients with osteoarthritis of the knee caused by aging.
The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31
Cash on hand	-	-	-	-	-	-	-
Receivables	$263	$257	$385	$247.45	$566	$755	$464
Inventory	$832	$901	$565	$526.54	$449	$339	$199
Pre-Paid Expenses	-	-	-	-	-	-	-
Other Current Assets	$156	$168	$33	$116.45	$77	$93	$61
Total Current Assets	$29,891	$30,627	$31,807	$34,391.42	$41,050	$43,408	-
Property, Plant, And Equipment	$12,395	$12,087	$11,740	$10,865	$5,332	$4,327	$1,125
Long-Term Investments	-	$2,961	$2,961	$1,525	$1,085	$494	-
Goodwill And Intangible Assets	$57	-	-	-	-	-	-
Other Long-Term Assets	$68	$1	$2,487	$1	$2	$2	$194
Total Long-Term Assets	$17,917	$15,118	$14,791	$12,456.85	-	-	-
Total Assets	$47,808	$45,746	$46,598	$46,848.27	$47,534	$48,289	$6,434
Total Current Liabilities	$810	$654	$659	$492.44	$20,322	$457	$274
Long Term Debt	$51	-	-	-	-	$19,883	-
Other Non-Current Liabilities	$2,375	$890	$265	$131	$150	$173	$148
Total Long Term Liabilities	$2,739	$889	$265	$129.68	-	-	-
Total Liabilities	$3,549	$1,543	$924	$622.12	$20,472	$20,513	$438
Common Stock Net	$26,753	$26,745	$26,744	$26,743	$16,511	$16,511	$5,428
Retained Earnings (Accumulated Deficit)	$-8,124	$-7,972	$-7,476	$-7,222.35	$-6,433	$-5,714	-
Comprehensive Income	-	-	-	-	-	-	-
Other Share Holders Equity	$-855	$-1,050	$-65	$25	$537	$530	-
Share Holder Equity	$44,268	$44,217	$45,698	$46,226.15	$27,062	$27,774	$5,996
Total Liabilities And Share Holders Equity	-	-	-	-	-	-	-

Annual Data | Millions of US $ except per share data

2020-03-31

2019-03-31

2018-03-31

2017-03-31

2016-03-31

2015-03-31

2014-03-31

Cash on hand

Receivables

$263

$257

$385

$247.45

$566

$755

$464

Inventory

$832

$901

$565

$526.54

$449

$339

$199

Pre-Paid Expenses

Other Current Assets

$156

$168

$33

$116.45

$77

$93

$61

Total Current Assets

$29,891

$30,627

$31,807

$34,391.42

$41,050

$43,408

Property, Plant, And Equipment

$12,395

$12,087

$11,740

$10,865

$5,332

$4,327

$1,125

Long-Term Investments

$2,961

$1,525

$1,085

$494

Goodwill And Intangible Assets

$57

Other Long-Term Assets

$68

$2,487

$194

Total Long-Term Assets

$17,917

$15,118

$14,791

$12,456.85

Total Assets

$47,808

$45,746

$46,598

$46,848.27

$47,534

$48,289

$6,434

Total Current Liabilities

$810

$654

$659

$492.44

$20,322

$457

$274

Long Term Debt

$51

$19,883

Other Non-Current Liabilities

$2,375

$890

$265

$131

$150

$173

$148

Total Long Term Liabilities

$2,739

$889

$265

$129.68

Total Liabilities

$3,549

$1,543

$924

$622.12

$20,472

$20,513

$438

Common Stock Net

$26,753

$26,745

$26,744

$26,743

$16,511

$5,428

Retained Earnings (Accumulated Deficit)

$-8,124

$-7,972

$-7,476

$-7,222.35

$-6,433

$-5,714

Comprehensive Income

Other Share Holders Equity

$-855

$-1,050

$-65

$25

$537

$530

Share Holder Equity

$44,268

$44,217

$45,698

$46,226.15

$27,062

$27,774

$5,996

Total Liabilities And Share Holders Equity

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31
Revenue	$1,792	$1,709	$1,728	$1,649.94	$1,264	$631	$456
Cost Of Goods Sold	$492	$481	$523	$570.99	$402	$360	$143
Gross Profit	-	-	-	-	-	-	-
Research And Development Expenses	$812	$998	$834	$902.87	$1,001	$983	$716
SG&A Expenses	$1,646	$1,454	$1,390	$1,348.20	$1,052	$982	$1,287
Other Operating Income Or Expenses	$249	$-101	$-79	$216	$216	$216	-
Operating Expenses	$2,830	$2,538	$2,387	$2,822.06	$2,557	$2,397	-
Operating Income	$-1,038	$-830	$-660	$-1,172.12	$-1,293	$-1,766	-
Total Non-Operating Income/Expense	-	-	-	-	-	-	-
Pre-Tax Income	$91	$-569	$-672	$-782.91	$-710	$-903	-
Income Taxes	$240	$74	$6	$6	$11	$11	$9
Income After Taxes	$240	$74	$6	$6	$11	$11	$9
Other Income	-	-	-	-	-	-	-
Income From Continuous Operations	$-149	$-643	$-678	$-789.33	$-721	$-914	-
Income From Discontinued Operations	-	-	-	-	-	-	-
Net Income	$-152	$-632	$-673	$-789.33	$-718	$-915	-
EBITDA	-	-	-	-	-	-	-
EBIT	$-1,038	$-830	$-660	$-1,172.12	$-1,293	$-1,766	-
Basic Shares Outstanding	-	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	-	-	-
Basic EPS	-	-	-	-	-	-	-
EPS - Earnings Per Share	-	-	-	-	-	-	-

Annual Data \| Millions of US $ except per share data	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31
Net Income/Loss	$-152	$-632	$-673	$-789.33	$-718	$-915	-
Total Depreciation And Amortization - Cash Flow	$492	$436	$399	$341.19	$280	$202	-
Change In Accounts Receivable	-	$128	$-6	$-30	$-9	$-141	-
Change In Inventories	$85	$-336	$-38	$-76.92	$-110	$-139	-
Cash Flow From Operating Activities	$-215	$-775	$-53	$575.44	$-258	$-779	-
Cash Flow From Investing Activities	$-244	$-1,917	$-2,484	$-5,547	$-482	$-26,780	$121
Debt Issuance/Retirement Net - Total	$-53	$-53	$-53	$-53	-	$20,394	-
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-	-
Financial Activities - Other	$1,304	$670	$-23	$-21	$-21	$-19	-
Cash Flow From Financial Activities	-	$670	$-23	$-109	$-21	$42,441	$4,050
Net Cash Flow	$840	$-2,025	$-2,558	$-5,083.24	$-762	$14,880	-
Common Stock Dividends Paid	-	-	-	-	-	-	-